Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | GLP1R | P43220 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.38 |
| ▸ | CDK1 | P06493 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30511849 | 1.00 | TP53 (0.49) | TP53CREBBPCHRM2CHRM4CHRM1 | |
| SCHEMBL28883032 | 0.84 | TSHR (0.55) | TP53CREBBPCHRM2CHRM4CHRM1 | |
| SCHEMBL23801864 | 0.79 | TP53 (0.54) | TP53CREBBPHDAC1HDAC6PTGS1 | |
| SCHEMBL8791684 | 0.78 | TP53 (0.60) | TP53CREBBPCHRM2CHRM4CHRM1 | |
| SCHEMBL2241939 | 0.78 | PTGS1 (0.49) | CHRM2CHRM4CHRM1CHRM3HDAC1 | |
| SCHEMBL13696680 | 0.77 | CHRM2 (0.59) | CHRM2CHRM4CHRM1CHRM3L3MBTL1 | |
| SCHEMBL30022454 | 0.77 | CHRM2 (0.59) | CHRM2CHRM4CHRM1CHRM3L3MBTL1 | |
| SCHEMBL30452765 | 0.77 | CHRM2 (0.46) | CREBBPCHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL22708510 | 0.75 | TP53 (0.46) | TP53CREBBPHDAC1HDAC6PTGS1 | |
| SCHEMBL17897786 | 0.74 | CHRM2 (0.50) | CHRM2CHRM4CHRM1CHRM3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112334454-B | Environment-friendly olefin hydration reaction | 佐治亚州立大学研究基金会公司 | 2024-04-30 | — | — | CN | disclosed |
| US-11708320-B2 | Environmentally-friendly hydroazidation of olefins | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708320-B2 | Environmentally-friendly hydroazidation of olefins | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-20210284601-A1 | ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-09-16 | — | — | US | disclosed |
| CN-112334454-A | Environmentally friendly olefin hydration reactions | 佐治亚州立大学研究基金会公司 | 2021-02-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708320-B2 | Environmentally-friendly hydroazidation of olefins | HAO2, AHR, HMOX1 | TP53 1404/4885CREBBP 2266/4885CHRM2 4323/4885 |
| US-20210284601-A1 | ENVIRONMENTALLY-FRIENDLY HYDROAZIDATION OF OLEFINS | HAO2, AHR, HMOX1 | TP53 1404/4885CREBBP 2266/4885CHRM2 4323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.